4.5 Article

Risk Factors Associated with Bleeding After Alteplase Administration for Pulmonary Embolism: A Case-Control Study

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism

Guy Meyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Moderate Pulmonary Embolism Treated With Thrombolysis (from the MOPETT Trial)

Mohsen Sharifi et al.

AMERICAN JOURNAL OF CARDIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association

Alan S. Go et al.

CIRCULATION (2013)

Review Pharmacology & Pharmacy

Clinical Controversies in Thrombolytic Therapy for the Management of Acute Pulmonary Embolism

Mitchell J. Daley et al.

PHARMACOTHERAPY (2012)

Article Medicine, General & Internal

Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic Therapy

Rajendra H. Mehta et al.

AMERICAN JOURNAL OF MEDICINE (2011)

Review Critical Care Medicine

Thrombolytic Therapy for Acute Pulmonary Embolism A Critical Appraisal

Jamie L. Todd et al.

CHEST (2009)

Article Medicine, General & Internal

Acute Pulmonary Embolism

Stavros Konstantinides

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism

K Fiumara et al.

AMERICAN JOURNAL OF CARDIOLOGY (2006)

Article Respiratory System

Efficacy of thrombolytic agents in the treatment of pulmonary embolism

T Capstick et al.

EUROPEAN RESPIRATORY JOURNAL (2005)

Article Medicine, General & Internal

Thrombolysis vs heparin in the treatment of pulmonary embolism - A clinical outcome-based meta-analysis

G Agnelli et al.

ARCHIVES OF INTERNAL MEDICINE (2002)